|
WO2004026868A1
|
|
N-substituted piperidinyl-imidazopyridine compounds as 5-ht4 receptor modulators
|
|
WO03064425A1
|
|
N-substituted spiropiperidine compounds as ligands for orl-1 receptor
|
|
WO03035649A1
|
|
Imidazopyridine compounds as 5-ht4 receptor modulators
|
|
JP2003055376A
|
|
Pyrazoloquinoline derivative as protein kinase c inhibitor
|
|
JP2003171377A
|
|
N-benzenesulfonyl-l-proline compound as bradykinin antagonist
|
|
JP2002330769A
|
|
Human vanilloid receptor-like protein
|
|
JP2002098049A
|
|
Sound insulation case
|
|
JP2002071672A
|
|
Permeability testing device and method
|
|
JP2001162971A
|
|
Duplication type form
|
|
JP2000080037A
|
|
5-lipoxygenase inhibitor and new medicine composition
|
|
JP2000001433A
|
|
5-lipoxygenase inhibitor
|
|
JP2000095292A
|
|
Support structure for tubelike member and method for fixing tubelike member
|
|
JP2000083650A
|
|
Automatic test device for testing enzymatic reaction
|
|
JPH1112250A
|
|
Hydrazide compound as kappa agonist
|
|
WO9830209A1
|
|
Rapidly releasing and taste-masking pharmaceutical dosage form
|
|
JPH1156258A
|
|
Preventive/therapeutic agent for pseudotuberculosis of fish
|
|
JPH1072464A
|
|
Piperidinylamino tricyclic compound as antagonist to substance p
|
|
JPH1149615A
|
|
Agrochemical preparation containing slightly water-soluble chemical and trunk-infusing agent using it
|
|
JPH10298062A
|
|
Rapidly dissolving type tablet in oral cavity
|
|
AU1396497A
|
|
1,4-dihydropyridine compounds as bradykinin antagonists
|
